Evidence map›Paper›PMID 21501254›Full record

ArticleThe European journal of neuroscience2011

A transgenic mouse model reveals fast nicotinic transmission in hippocampal pyramidal neurons.

Michael J Grybko, Eu-Teum Hahm, Wesley Perrine, Jason A Parnes, Wallace S Chick, Geeta Sharma, Thomas E Finger, Sukumar Vijayaraghavan

Open access · greenAbstract read
In one paragraph

Article in The European journal of neuroscience, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 55 citations in OpenAlex.

  1. Article
  2. Article
  3. Cholinergic regulation of dendritic CaProceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Memantine has a nicotinic neuroprotective pathway in acute hippocampal slices after an NMDA insult.Toxicology in vitro : an international journal published in association with BIBRA · 2022
    Article
  11. Article
  12. Article
  13. Article
  14. Therapeutic Targeting ofPharmacological reviews · 2021
    Review
  15. Article
  16. Article
  17. Visualization of Neuronal Structures in Wide-Field Microscopy Brain Images.IEEE transactions on visualization and computer graphics · 2018
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Michael J GrybkoDepartment of Physiology and Biophysics, School of Medicine, University of Colorado, Aurora, CO, USA.
Eu-Teum Hahm
Wesley Perrine
Jason A Parnes
Wallace S Chick
Geeta Sharma
Thomas E Finger
Sukumar Vijayaraghavan
University of Colorado Anschutz Medical Campus · USUniversity of Colorado Denver · USRocky Mountain MS Center · US

Funding

NIDCD P30 Core: Rocky Mountain Taste and Smell CenterP30DC004657 · NIDCD · UNIVERSITY OF COLORADO DENVER · PI KINNAMON, SUE C., RESTREPO, DIEGO · 2000 to 2014
$7.6M
Multiple Mechanisms of Nasal ChemoreceptionR01DC006070 · NIDCD · UNIVERSITY OF COLORADO DENVER · PI FINGER, THOMAS E, RESTREPO, DIEGO · 2003 to 2012
$5.0M
Cholinergic Modulation of OlfactionR01DC008855 · NIDCD · UNIVERSITY OF COLORADO DENVER · PI VIJAYARAGHAVAN, SUKUMAR · 2007 to 2018
$3.2M
Nicotinic Signaling in the BrainR01DA010266 · NIDA · UNIVERSITY OF COLORADO DENVER · PI VIJAYARAGHAVAN, SUKUMAR · 1998 to 2012
$2.8M
Cholinergic Signaling in the BrainR21DA019453 · NIDA · UNIVERSITY OF COLORADO DENVER · PI VIJAYARAGHAVAN, SUKUMAR · 2005 to 2006
$272k
NIDA NIH HHS R01 DA010266NIDA NIH HHS R01DA 10266NIDA NIH HHS R21 DA 019453NIDA NIH HHS R21 DA019453NIDCD NIH HHS P30 DC004657NIDCD NIH HHS P30 DC04657NIDCD NIH HHS R01 DC006070NIDCD NIH HHS R01 DC008855NIDCD NIH HHS R01DC008855
6 · The paper itself

Abstract

The relative contribution to brain cholinergic signaling by synaptic- and diffusion-based mechanisms remains to be elucidated. In this study, we examined the prevalence of fast nicotinic signaling in the hippocampus. We describe a mouse model where cholinergic axons are labeled with the tauGFP fusion protein driven by the choline acetyltransferase promoter. The model provides for the visualization of individual cholinergic axons at greater resolution than other available models and techniques, even in thick, live, slices. Combining calcium imaging and electrophysiology, we demonstrate that local stimulation of visualized cholinergic fibers results in rapid excitatory postsynaptic currents mediated by the activation of α7-subunit-containing nicotinic acetylcholine receptors (α7-nAChRs) on CA3 pyramidal neurons. These responses were blocked by the α7-nAChR antagonist methyllycaconitine and potentiated by the receptor-specific allosteric modulator 1-(5-chloro-2,4-dimethoxy-phenyl)-3-(5-methyl-isoxanol-3-yl)-urea (PNU-120596). Our results suggest, for the first time, that synaptic nAChRs can modulate pyramidal cell plasticity and development. Fast nicotinic transmission might play a greater role in cholinergic signaling than previously assumed. We provide a model for the examination of synaptic properties of basal forebrain cholinergic innervation in the brain.

Indexed as

Mice, TransgenicAcetylcholinealpha7 Nicotinic Acetylcholine ReceptorAnimalsCholine O-AcetyltransferaseExcitatory Postsynaptic PotentialsHippocampusMiceNervous SystemNicotinic AntagonistsPatch-Clamp TechniquesPyramidal CellsReceptors, NicotinicRecombinant Fusion ProteinsSynaptic TransmissionTransgenesAcetylcholinealpha7 Nicotinic Acetylcholine ReceptorCholine O-AcetyltransferaseChrna7 protein, mouseNicotinic AntagonistsReceptors, NicotinicRecombinant Fusion Proteins

Identifiers

PMID21501254
PMCPMC3095690
OpenAlexW1593953808

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.